Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2012 Results
Date:2/13/2013

be in a range of $2.05 to $2.20, representing growth of 2 to 9 percent.

The reconciliation between the projected 2013 adjusted* diluted earnings per share and projected GAAP diluted earnings per share follows:

Diluted earnings per share -- adjusted*$2.05 - $2.20Estimated amortization of intangible assets related to certain acquisitions (mid-point of an estimated range of $0.29 to $0.33 per diluted share)$(0.31)Estimated charges for certain quality and product-related matters (mid-point of an estimated range of $0.15 to $0.23 per diluted share)$(0.19)Estimated charges related to capacity expansion (mid-point of an estimated range of $0.15 to $0.19 per diluted share)$(0.17)Estimated acquisition and integration-related charges associated with the pending acquisition of an API-related business from Orchid Chemicals & Pharmaceuticals (mid-point of an estimated range of $0.04 to $0.06 per diluted share)$(0.05)Estimated charges related to facilities optimization (mid-point of an estimated range of $0.00 to $0.02 per diluted share)$(0.01)Diluted earnings per share -- GAAP$1.32 - $1.47The adjusting items are shown net of tax in aggregate of $57 million, which is calculated for the specified adjustments stated above, based on the statutory tax rates in the various tax jurisdictions in which the items are expected to occur.

The company projects that cash flow from operations in 2013 will range between $350 million and $400 million. Depreciation and amortization is expected to be $255 million to $275 million. Capital expenditures are projected to range between $425 million and $475 million.

*Use of Non-GAAP Financial MeasuresAdjusted measures used in this press release are reconciled to the most comparable measures calculated in accordance with GAAP in the schedules attached to this release. For more information
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hospira to Present at Upcoming Investor Conferences
2. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
3. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
4. Hospira Reports Third-Quarter 2012 Results
5. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
6. Hospira Reports Second-Quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira to Host Conference Call for Second-quarter 2012 Results
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
11. Hospira to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... (Allscripts – NASDAQ: MDRX ) today announced its ... (Logo:   http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) Third ... million, compared to $198.6 million in the third quarter of ... of $368.8 million; non-GAAP revenue of $371.4 million, a 13 ...
...  Prescription copay coupon marketing programs, which lure insured consumers ... increase costs by $32 billion over the next decade, ... by the Pharmaceutical Care Management Association (PCMA). ... undermine efforts by employers, unions and state governments to ...
Cached Medicine Technology:Allscripts Reports Third Quarter 2011 Results 2Allscripts Reports Third Quarter 2011 Results 3Allscripts Reports Third Quarter 2011 Results 4Allscripts Reports Third Quarter 2011 Results 5Allscripts Reports Third Quarter 2011 Results 6Allscripts Reports Third Quarter 2011 Results 7Allscripts Reports Third Quarter 2011 Results 8Allscripts Reports Third Quarter 2011 Results 9Allscripts Reports Third Quarter 2011 Results 10Allscripts Reports Third Quarter 2011 Results 11Allscripts Reports Third Quarter 2011 Results 12Allscripts Reports Third Quarter 2011 Results 13Allscripts Reports Third Quarter 2011 Results 14Allscripts Reports Third Quarter 2011 Results 15Allscripts Reports Third Quarter 2011 Results 16Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion 2
(Date:8/30/2014)... August 30, 2014 The federal ... lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific ... four cases selected for one of the proceeding’s ... August 18, 2014, U.S. District Judge Joseph R. ... disagrees with Boston Scientific’s contention that a consolidated ...
(Date:8/30/2014)... August 2014: Transvenous lead extraction (TLE) is clinically successful ... from the European Lead Extraction ConTRolled (ELECTRa) registry presented ... by Dr Maria Grazia Bongiorni, chair of the registry,s ... cardiac implantable electronic devices (CIED) implant procedures has grown ... of complications has increased and leads are often the ...
(Date:8/30/2014)... 2014 In today’s world, a good ... to get. Snoring and sleep apnea (a medical problem ... robs people and their bed partners of the rest ... 45% of the population snores and 20 million people ... these, only 10% have been diagnosed and treated; and ...
(Date:8/30/2014)... Top10BestSEOHosting.com is a well-known review website. Recently, ... http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the best Windows Hosting ... announced that Bluehost and Arvixe are excellent companies ... the Top 10 Web Hosting in 2014, is ... it offers rich features and great Windows hosting ...
(Date:8/30/2014)... August 30, 2014 Removecomplaints.net, a well-known ... industry, has announced to offer guarantee of results with ... offer this guarantee because of its tremendous track record. ... clients from all over the world and received recommendation ... job. , On being asked about the announcement, ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Removecomplaints.net Announces Guaranteed Complaints Removal Services 2
... the Company,s line of health and beauty strategic ... AdEx Media, Inc. (OTC Bulletin Board: ADXM), ... platform services company, today announced the addition of ... product strategic partnerships. RezActiv(TM) was formulated by ...
... to outlook of $65.0 to $69.0 million- Case shipments of ... - GAAP diluted EPS of $0.04, compared to outlook of ... (Nasdaq: ALGN ) today reported financial results for ... Total net revenues for the first quarter of fiscal 2009 ...
... exposure and its associated risks, according to a study ... , "More than 100 surveys were completed by physicians ... tertiary-care teaching hospital," said Jeremy McBride, MD, lead author ... assessed, 63% underestimated the radiation dose of one abdominal-pelvic ...
... 23 Last night, Oklahoma Governor Brad Henry vetoed ... for any Oklahoma business to conduct research that would ... to a substantial risk of death or injury. ... however, the Oklahoma Senate failed to follow suit.The bill ...
... one of the market,s leading Security as a Service ... Trust Award for "Best Managed Security Service" for the ... at the exclusive, SC Magazine Awards Gala, held in ... Managed Security Services competed against those from MessageLabs (now ...
... VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ... for its lead oncology therapeutic Onrigin(TM) (laromustine) Injection has ... and Drug Administration (FDA). Therefore, a user fee goal ... the FDA with respect to the approval of the ...
Cached Medicine News:Health News:AdEx Media Introduces RezActiv(TM) 2Health News:AdEx Media Introduces RezActiv(TM) 3Health News:Align Technology Announces First Quarter Fiscal 2009 Results 2Health News:Align Technology Announces First Quarter Fiscal 2009 Results 3Health News:Align Technology Announces First Quarter Fiscal 2009 Results 4Health News:Align Technology Announces First Quarter Fiscal 2009 Results 5Health News:Align Technology Announces First Quarter Fiscal 2009 Results 6Health News:Align Technology Announces First Quarter Fiscal 2009 Results 7Health News:Align Technology Announces First Quarter Fiscal 2009 Results 8Health News:Align Technology Announces First Quarter Fiscal 2009 Results 9Health News:Align Technology Announces First Quarter Fiscal 2009 Results 10Health News:Align Technology Announces First Quarter Fiscal 2009 Results 11Health News:Align Technology Announces First Quarter Fiscal 2009 Results 12Health News:Align Technology Announces First Quarter Fiscal 2009 Results 13Health News:Majority of ordering physicians lack knowledge of radiation exposure risks from CT 2Health News:SecureWorks, Inc. Wins SC Magazine's Reader Trust Award for Best Managed Security Service for Four Years Running 2Health News:Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM) 2Health News:Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: